A5025001118- Ovarian function and disorders
- Assisted Reproductive Technology and Twin Pregnancy
- Reproductive Biology and Fertility
- Reproductive Health and Technologies
- Gynecological conditions and treatments
- Prenatal Screening and Diagnostics
- Endometriosis Research and Treatment
- Reproductive Health and Contraception
- Sperm and Testicular Function
- Uterine Myomas and Treatments
- Renal and related cancers
- Maternal and Perinatal Health Interventions
- Sexual function and dysfunction studies
- Menstrual Health and Disorders
- Maternal and fetal healthcare
- Substance Abuse Treatment and Outcomes
- Urologic and reproductive health conditions
- Breastfeeding Practices and Influences
- Muscle and Compartmental Disorders
- Family Dynamics and Relationships
- Growth Hormone and Insulin-like Growth Factors
- Pluripotent Stem Cells Research
- Pituitary Gland Disorders and Treatments
- Reproductive tract infections research
- Reproductive Physiology in Livestock
Icahn School of Medicine at Mount Sinai
2025
Reproductive Medicine Associates of New York
2023-2025
University of Southern California
2019-2022
Drexel University
2014-2017
Hahnemann University Hospital
2016-2017
Cornell University
2010
To determine if the biologically active or bioavailable inhibin B (bio-inhB) correlated with oocyte yield in controlled ovarian stimulation (COS).Cross-sectional study.Academic center.Women undergoing cryopreservation.None.Serum of women were sampled to measure bio-inhB at three points: baseline ("start"); middle ("mid"); and end COS. A validated, highly specific enzyme-linked immunosorbent assay (Ansh Labs, Webster, TX) measured bio-inhB. The Spearman tests analyzed correlations between...
To investigate the efficacy of elagolix when administered at different time points in a menstrual cycle.Clinical case series.Academic reproductive endocrinology center.Ovulatory women not desiring pregnancy.Six doses 200 mg were over 4 days, starting 3 cycle: early follicular; late and midluteal. Serum follicle-stimulating hormone (FSH), luteinizing (LH), estradiol (E2), progesterone (P) concentrations measured baseline, during administration, 1 day after last dose. Transvaginal ultrasounds...
The female infertility experience is well-described, but the male less explored. We sought to understand if fertility motivations and quality of life differ for males undergoing evaluation by a reproductive urologist (RU) versus endocrinologist (RE). A cross-sectional study 201 at an academic centre, either RU or RE, over 2-year period, was performed. survey administered, with demographic, medical, questions, validated Fertility Quality Life (FertiQoL) questionnaire. Responses were compared...
INTRODUCTION: Improving access to postpartum sterilization and a trial of labor after cesarean delivery (TOLAC) are both stated goals the American College Obstetricians Gynecologists. Cesarean is known increase odds receiving sterilization. Opting for TOLAC may significantly reduce likelihood patients their desired procedure. METHODS: A record review who signed Medicaid consent form (MA31) between August 2012 December 2013 at single site was performed. Information on patient demographics...
Postpartum sterilization is a popular and effective method of contraception in the United States. As 2012, postpartum was performed after 10% all hospital deliveries, which equated to approximately 400,000 procedures annually [1,2]. Sterilization can be conveniently at time cesarean delivery or immediate period vaginal [1]. Advantages include technical ease, one-time use anesthesia case patient receiving an epidural during labor, utilization current hospitalization, increased compliance,...